Stocks and Investing Stocks and Investing
Wed, March 17, 2021
[ 12:00 AM ] - WOPRAI
Steve Enders Maintained (SMAR) at Buy with Increased Target to $84 on, Mar 17th, 2021
[ 12:00 AM ] - WOPRAI
Mark Murphy Upgraded (SMAR) to Buy and Held Target at $83 on, Mar 17th, 2021
[ 12:00 AM ] - WOPRAI
Keith Bachman Maintained (SMAR) at Buy with Decreased Target to $83 on, Mar 17th, 2021
[ 12:00 AM ] - WOPRAI
Michael Ciarmoli Initiated (SPCE) at Strong Buy on, Mar 17th, 2021
[ 12:00 AM ] - WOPRAI
Steven Cahill Initiated (CABO) at Buy on, Mar 17th, 2021
[ 12:00 AM ] - WOPRAI
Douglas Tsao Maintained (CABA) at Strong Buy with Increased Target to $22 on, Mar 17th, 2021
[ 12:00 AM ] - WOPRAI
Truman Patterson Initiated (BECN) at Hold on, Mar 17th, 2021
[ 12:00 AM ] - WOPRAI
Andrew Kligerman Maintained (BHF) at Hold with Increased Target to $42 on, Mar 17th, 2021
[ 12:00 AM ] - WOPRAI
Karl Ackerman Upgraded (STX) to Buy and Increased Target to $95 on, Mar 17th, 2021
[ 12:00 AM ] - WOPRAI
Douglas Harter Maintained (STWD) at Buy with Increased Target to $26 on, Mar 17th, 2021
[ 12:00 AM ] - WOPRAI
Steve Fleishman Downgraded (VST) to Hold and Decreased Target to $20 on, Mar 17th, 2021
[ 12:00 AM ] - WOPRAI
Shahriar Pourreza Downgraded (VST) to Hold on, Mar 17th, 2021
[ 12:00 AM ] - WOPRAI
Justin Jenkins Maintained (VLO) at Buy with Increased Target to $96 on, Mar 17th, 2021
[ 12:00 AM ] - WOPRAI
Zachary Fadem Maintained (AAP) at Hold with Increased Target to $185 on, Mar 17th, 2021
[ 12:00 AM ] - WOPRAI
Suji Desilva Initiated (AEVA) at Strong Buy and Held Target at $150 on, Mar 17th, 2021
[ 12:00 AM ] - WOPRAI
Richard Shannon Initiated (AEVA) at Strong Buy and Held Target at $125 on, Mar 17th, 2021
[ 12:00 AM ] - WOPRAI
Brent Thill Maintained (ADBE) at Strong Buy and Held Target at $600 on, Mar 17th, 2021
[ 12:00 AM ] - WOPRAI
Douglas Harter Maintained (ACRE) at Buy with Increased Target to $16 on, Mar 17th, 2021
[ 12:00 AM ] - WOPRAI
Amit Dayal Maintained (WPRT) at Strong Buy on, Mar 17th, 2021
[ 12:00 AM ] - WOPRAI
Chris Terry Upgraded (AA) to Strong Buy and Held Target at $36 on, Mar 17th, 2021
[ 12:00 AM ] - WOPRAI
Justin Jenkins Maintained (BP) at Buy with Increased Target to $29 on, Mar 17th, 2021
[ 12:00 AM ] - WOPRAI
Douglas Harter Maintained (BXMT) at Hold with Increased Target to $33 on, Mar 17th, 2021
[ 12:00 AM ] - WOPRAI
Douglas Harter Maintained (ARI) at Hold with Increased Target to $15 on, Mar 17th, 2021
[ 12:00 AM ] - WOPRAI
Gregory Renza Maintained (APRE) at Hold with Decreased Target to $160 on, Mar 17th, 2021
[ 12:00 AM ] - WOPRAI
Stephen Sheldon Initiated (APEI) at Buy on, Mar 17th, 2021
[ 12:00 AM ] - WOPRAI
George Hill Maintained (TDOC) at Strong Buy with Decreased Target to $226 on, Mar 17th, 2021
[ 12:00 AM ] - WOPRAI
Colin Isaac Downgraded (AVY) to Hold on, Mar 17th, 2021
[ 12:00 AM ] - WOPRAI
Steven Cahill Initiated (ATUS) at Hold and Held Target at $33 on, Mar 17th, 2021
[ 12:00 AM ] - WOPRAI
Bryan Keane Maintained (AFRM) at Hold with Decreased Target to $92 on, Mar 17th, 2021
[ 12:00 AM ] - WOPRAI
Ed Arce Maintained (AKRO) at Strong Buy with Decreased Target to $61 on, Mar 17th, 2021

Ed Arce Maintained (AKRO) at Strong Buy with Decreased Target to $61 on, Mar 17th, 2021


Published on 2024-10-27 15:57:52 - WOPRAI, Ed Arce
  Print publication without navigation


Ed Arce of HC Wainwright & Co., Maintained "Akero Therapeutics, Inc." (AKRO) at Strong Buy with Decreased Target from $64 to $61 on, Mar 17th, 2021.

Ed has made no other calls on AKRO in the last 4 months.



There is 1 other peer that has a rating on AKRO. Out of the 1 peers that are also analyzing AKRO, 0 agree with Ed's Rating of Hold.



This is the rating of the analyst that currently disagrees with Ed

  • Etzer Darout of "Guggenheim" Initiated at Strong Buy and Held Target at $54 on, Friday, February 26th, 2021
Contributing Sources